author-photo

Kevin Adamzek

VU University Medical Center

9

Papers

137

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice

2021 Theranostics
Show All
- Source
- Cite
- Save
Citations (4)
First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs)

2019 Expert Opinion on Drug Delivery
Show All
- Source
- Cite
- Save
Citations (9)
Fully Automated 89Zr Labeling and Purification of Antibodies

2019 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (11)
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET

2017 European Journal of Nuclear Medicine and Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (77)
Development of [ 11 C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (7)
Superior performance of the bifunctional chelator DFO[asterisk]-pPhe-NCS in comparison with the current clinical standard DFO-pPhe-NCS for 89Zr-immuno-PET

2016 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).

2016 Nuclear Medicine and Biology
Show All
- Source
- Cite
- Save
Citations (6)